Top

The Patient - Patient-Centered Outcomes Research

Published in:

Open Access 09-05-2024 | Atopic Dermatitis | Systematic Review

Treatment Preference Research in Atopic Dermatitis: A Systematic Review of Quantitative Studies

Authors: Katja C. Heinz, Charlotte Beaudart, Damon Willems, Mickaël Hiligsmann

Published in: The Patient - Patient-Centered Outcomes Research | Issue 5/2024

Abstract

Background

Treatment preference research can support shared and informed decision making for currently available atopic dermatitis (AD) treatments, and simultaneously guide research and development for future therapies. In this systematic literature review, we aimed to provide an overview of preferences for AD treatments.

Methods

This systematic literature review was conducted in the Medline and Embase (via Ovid) databases, supplemented by manual searching. Quantitative research published from 2010 to September 2023 that investigated preferences for AD treatments were included. Quality assessment was conducted by using the purpose, respondents, explanation, findings, significance checklist, and a checklist developed by the Professional Society for Health Economics and Outcomes Research.

Results

In total, 207 references were screened after removing duplicates and 15 studies were included. Most studies were conducted in the US, followed by European countries. On average, people directly or indirectly affected by AD rate efficacy and treatment-related risk as the most important criteria when choosing an AD therapy. Participants are willing to increase risks in order to have a higher chance of achieving a certain benefit, e.g. reduction in itch or clearer skin. Participants have preferences for different modes of administration. On average, 68% (all full-text studies) and 87% (only discrete choice experiments [DCEs]) of quality criteria per reference were rated as fulfilled. DCEs received generally higher quality assessment scores than non-DCEs.

Conclusions

This review revealed that AD treatment preference research is limited. Diverse study designs hampered comparison and synthesis of the results. We recommend conducting more DCEs in this field to increase the likelihood of AD patients receiving the therapy that best fits their individual needs and preferences.

Clinical Trials Registration

This protocol was published in PROSPERO (ID: CRD42023468757).

Available only for authorised users

Williams HC. Atopic dermatitis: the epidemiology, causes and prevention of atopic eczema. Cambridge: Cambridge University Press; 2000.CrossRef

Love I, White K. Atopic dermatitis/atopic eczema: disease landscape & forecast. Decision Resources Group; 2020.

Senra MS, Wollenberg A. Psychodermatological aspects of atopic dermatitis. Br J Dermatol. 2014;170(Suppl 1):38–43. https://doi.org/10.1111/bjd.13084.CrossRefPubMed

Vakharia PP, Chopra R, Sacotte R, Patel KR, Singam V, Patel N, et al. Burden of skin pain in atopic dermatitis. Ann Allergy Asthma Immunol. 2017;119:548-552.e3. https://doi.org/10.1016/j.anai.2017.09.076.CrossRefPubMedPubMedCentral

Cheng C-M, Hsu J-W, Huang K-L, Bai Y-M, Su T-P, Li C-T, et al. Risk of developing major depressive disorder and anxiety disorders among adolescents and adults with atopic dermatitis: a nationwide longitudinal study. J Affect Disord. 2015;178:60–5. https://doi.org/10.1016/j.jad.2015.02.025.CrossRefPubMed

Avail Dermatology. Top 5 most common skin conditions. 2018. https://availdermatology.com/common-skin-conditions/. Accessed 18 Dec 2022.

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121:340–7. https://doi.org/10.1016/j.anai.2018.07.006.CrossRefPubMed

Ariëns LFM, van Nimwegen KJM, Shams M, de Bruin DT, van der Schaft J, van Os-Medendorp H, de Bruin-Weller M. Economic burden of adult patients with moderate to severe atopic dermatitis indicated for systemic treatment. Acta Derm Venereol. 2019;99:762–8. https://doi.org/10.2340/00015555-3212.CrossRefPubMed

National Institute for Health and Care Excellence. Dupilumab for treating moderate to severe atopic dermatitis: technology appraisal guidance [TA534]. 2018. https://www.nice.org.uk/guidance/TA534. Accessed 18 Dec 2022.

10.

van Overbeeke E, Janssens R, Whichello C, Schölin Bywall K, Sharpe J, Nikolenko N, et al. Design, conduct, and use of patient preference studies in the medical product life cycle: a multi-method study. Front Pharmacol. 2019;10:1395. https://doi.org/10.3389/fphar.2019.01395.CrossRefPubMedPubMedCentral

11.

Maleki-Yazdi KA, Heen AF, Zhao IX, Guyatt GH, Suzumura EA, Makhdami N, et al. Values and preferences of patients and caregivers regarding treatment of atopic dermatitis (eczema): a systematic review. JAMA Dermatol. 2023;159:320–30. https://doi.org/10.1001/jamadermatol.2022.6045.CrossRefPubMed

12.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, The PRISMA, et al. statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021:372. https://doi.org/10.1136/bmj.n71.CrossRef

13.

Morrison A, Polisena J, Husereau D, Moulton K, Clark M, Fiander M, et al. The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care. 2012;28:138–44. https://doi.org/10.1017/S0266462312000086.CrossRefPubMed

14.

Dobrescu AI, Nussbaumer-Streit B, Klerings I, Wagner G, Persad E, Sommer I, et al. Restricting evidence syntheses of interventions to English-language publications is a viable methodological shortcut for most medical topics: a systematic review. J Clin Epidemiol. 2021;137:209–17. https://doi.org/10.1016/j.jclinepi.2021.04.012.CrossRefPubMed

15.

Centre for Reviews and Dissemination. Systematic Reviews: CRD’s guidance for undertaking reviews in health care. York: University of York; 2009.

16.

Veritas Health Innovation. Covidence systematic review software. 2023. http://www.covidence.org. Accessed 25 Nov 2023.

17.

Nelson HD. Systematic reviews to answer health care questions. Philadelphia: Wolters Kluwer Health; 2014.

18.

Bien DR, Danner M, Vennedey V, Civello D, Evers SM, Hiligsmann M. Patients’ preferences for outcome, process and cost attributes in cancer treatment: a systematic review of discrete choice experiments. The Patient. 2017;10:553–65. https://doi.org/10.1007/s40271-017-0235-y.CrossRefPubMedPubMedCentral

19.

Sharma P, Kularatna S, Abell B, Eagleson K, Vo LK, Halahakone U, et al. Preferences in the design and delivery of neurodevelopmental follow-up care for children: a systematic review of discrete choice experiments. Patient Prefer Adher. 2023;17:2325–41. https://doi.org/10.2147/PPA.S425578.CrossRef

20.

Joy SM, Little E, Maruthur NM, Purnell TS, Bridges JFP. Patient preferences for the treatment of type 2 diabetes: a scoping review. Pharmacoeconomics. 2013;31:877–92. https://doi.org/10.1007/s40273-013-0089-7.CrossRefPubMed

21.

Bridges JFP, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, et al. Conjoint analysis applications in health–a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14:403–13. https://doi.org/10.1016/j.jval.2010.11.013.CrossRefPubMed

22.

Boeri M, Sutphin J, Hauber B, Cappelleri JC, Romero W, Di Bonaventura M. Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experiment. J Dermatol Treat. 2022;33:1449–58. https://doi.org/10.1080/09546634.2020.1832185.CrossRef

23.

Carrascosa Carrillo JM, Baselga Torres E, Gilaberte Calzada Y, Jurgens Martínez YN, Roustan Gullón G, Yanguas Bayona JI, et al. Quantifying physician preferences for systemic atopic dermatitis treatments using a discrete-choice experiment. Dermatol Ther (Heidelb). 2022;12:1197–210. https://doi.org/10.1007/s13555-022-00723-z.CrossRefPubMedPubMedCentral

24.

Hon K-LE, Wang SS, Pong NH, Leung TF. The ideal moisturizer: a survey of parental expectations and practice in childhood-onset eczema. J Dermatolog Treat. 2013;24:7–12. https://doi.org/10.3109/09546634.2012.672713.

25.

Kwatra SG, Lio P, Weidinger S, Calimlim B, Ladizinski B, Vigna N, et al. Patient preferences for atopic dermatitis treatments: a discrete choice experiment. J Dermatol Treat. 2023;34:2222201. https://doi.org/10.1080/09546634.2023.2222201.CrossRef

26.

Myers K, Silverberg JI, Parasuraman S, Pierce A, Eichenfield LF, Poulos C. Treatment preferences among patients with mild-to-moderate atopic dermatitis. J Dermatol Treat. 2023;34:2215356. https://doi.org/10.1080/09546634.2023.2215356.CrossRef

27.

Okubo Y, Ho K-A, Fifer S, Fujita H, Oki Y, Taguchi Y. Patient and physician preferences for atopic dermatitis injection treatments in Japan. J Dermatol Treat. 2020;31:821–30. https://doi.org/10.1080/09546634.2019.1623860.CrossRef

28.

Thomas C, Raibouaa A, Wollenberg A, Capron J-P, Krucien N, Karn H, Tervonen T. Patient preferences for atopic dermatitis medications in the UK, France and Spain: a discrete choice experiment. BMJ Open. 2022;12: e058799. https://doi.org/10.1136/bmjopen-2021-058799.CrossRefPubMedPubMedCentral

29.

Cadmus SD, Sebastian KR, Warren D, Hovinga CA, Croce EA, Reveles LA, et al. Efficacy and patient opinion of wet-wrap dressings using 0.1% triamcinolone acetonide ointment vs cream in the treatment of pediatric atopic dermatitis: a randomized split-body control study. Pediatr Dermatol. 2019;36:437–41. https://doi.org/10.1111/pde.13830.

30.

Egeberg A, Thyssen JP. Factors associated with patient-reported importance of skin clearance among adults with psoriasis and atopic dermatitis. J Am Acad Dermatol. 2019;81:943–9. https://doi.org/10.1016/j.jaad.2019.06.018.CrossRefPubMed

31.

Joergensen KM, Jemec GBE. Use of moisturizers among Danish atopic dermatitis patients-which perceived product characteristics associate with long-term adherence? J Dermatol Treat. 2018;29:116–22. https://doi.org/10.1080/09546634.2017.1358803.CrossRef

32.

Kunkiel K, Natkańska A, Nędzi M, Zawadzka-Krajewska A, Feleszko W. Patients’ preferences of leave-on emollients: a survey on patients with atopic dermatitis. J Dermatol Treat. 2022;33:1143–5. https://doi.org/10.1080/09546634.2020.1772452.CrossRef

33.

Ito K, Imafuku S, Nakayama J. Therapeutic preferences are different in psoriatic and atopic dermatitis patients: a questionnaire-based study. J Dermatol. 2013;40:292–4. https://doi.org/10.1111/1346-8138.12094.CrossRefPubMed

34.

Johnson MC, Heron CE, Feldman SR. Caregiver preferences for the treatment of childhood atopic dermatitis. J Cutan Med Surg. 2021;25:336–8. https://doi.org/10.1177/1203475420988866.CrossRefPubMed

35.

Barrera T, Margolis D, Fuxench ZCC. 555 Treatment preferences in adult patients with atopic dermatitis. J Investig Dermatol. 2023;143:S95. https://doi.org/10.1016/j.jid.2023.03.561.CrossRef

36.

Prajapati VH, Eichenfield LF, Schuttlelaar ML, Ladizinski B, Vigna N, Chen N, et al. Preference for oral versus injectable treatment in adults with moderate-to-severe atopic dermatitis: results from the phase 3b heads up clinical trial. In: 4th annual revolutionizing atopic dermatitis (RAD) conference 9–11 April 2022; Baltimore, MD.

37.

Laba T-L, Brien J, Fransen M, Jan S. Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS). BMC Musculoskelet Disord. 2013;14:160. https://doi.org/10.1186/1471-2474-14-160.CrossRefPubMedPubMedCentral

38.

Blaiss MS, Steven GC, Bender B, Bukstein DA, Meltzer EO, Winders T. Shared decision making for the allergist. Ann Allergy Asthma Immunol. 2019;122:463–70. https://doi.org/10.1016/j.anai.2018.08.019.CrossRefPubMed

Title: Treatment Preference Research in Atopic Dermatitis: A Systematic Review of Quantitative Studies
Authors: Katja C. Heinz
Charlotte Beaudart
Damon Willems
Mickaël Hiligsmann
Publication date: 09-05-2024
Publisher: Springer International Publishing
Keyword: Atopic Dermatitis
Published in: The Patient - Patient-Centered Outcomes Research / Issue 5/2024
Print ISSN: 1178-1653
Electronic ISSN: 1178-1661
DOI: https://doi.org/10.1007/s40271-024-00698-3

Consumer Preferences for a Healthcare Appointment Reminder in Australia: A Discrete Choice Experiment

Open Access
Original Research Article

Practices and Barriers in Developing and Disseminating Plain-Language Resources Reporting Medical Research Information: A Scoping Review

Open Access
Scoping Review

Making Use of Technology to Improve Stated Preference Studies

Practical Application

Development of Patient and Caregiver Conceptual Models Investigating the Health-Related Quality of Life Impacts of Malignant Pleural Mesothelioma

Pleural Mesothelioma
Original Research Article

Optimizing Communication on HPV Vaccination to Parents of 11- to 14-Year-Old Adolescents in France: A Discrete Choice Experiment

Open Access
Vaccination
Original Research Article

Eliciting Older Cancer Patients’ Preferences for Follow-Up Care to Inform a Primary Healthcare Follow-Up Model in China: A Discrete Choice Experiment

Open Access
Original Research Article

Keynote series | Spotlight on managing health in obesity

Obesity
Video Series

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman

Prof. Jonette Keri

Developed by: Springer Medicine

Watch now

Women’s health knowledge hub

Menopause
Clinical Collection

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Live
Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital

Prof. Ronald F. van Vollenhoven

Developed by: Springer Medicine

Navigating neuroimaging in Alzheimer disease care

Springer Medicine

Treatment Preference Research in Atopic Dermatitis: A Systematic Review of Quantitative Studies